Synergy Innovation Co. Ltd - Asset Resilience Ratio

Latest as of September 2025: 18.41%

Synergy Innovation Co. Ltd (048870) has an Asset Resilience Ratio of 18.41% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Synergy Innovation Co. Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩61.74 Billion
≈ $41.84 Million USD Cash + Short-term Investments

Total Assets

₩335.45 Billion
≈ $227.33 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2006–2024)

This chart shows how Synergy Innovation Co. Ltd's Asset Resilience Ratio has changed over time. See 048870 net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Synergy Innovation Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Synergy Innovation Co. Ltd stock valuation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩61.74 Billion 18.41%
Total Liquid Assets ₩61.74 Billion 18.41%

Asset Resilience Insights

  • Good Liquidity Position: Synergy Innovation Co. Ltd maintains a healthy 18.41% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Synergy Innovation Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Synergy Innovation Co. Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Ascendis Pharma AS
NASDAQ:ASND
Biotechnology 0.00%
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Biotechnology 0.00%
Spyre Therapeutics Inc.
NASDAQ:SYRE
Biotechnology 84.34%
3SBio Inc
F:83B
Biotechnology 10.64%
Soleno Therapeutics Inc
NASDAQ:SLNO
Biotechnology 20.15%
Jiangxi Fushine Pharmaceutical Co Ltd
SHE:300497
Biotechnology 0.02%
Novavax Inc
NASDAQ:NVAX
Biotechnology 53.87%
BB Biotech AG
SW:BION
Biotechnology 0.05%

Annual Asset Resilience Ratio for Synergy Innovation Co. Ltd (2006–2024)

The table below shows the annual Asset Resilience Ratio data for Synergy Innovation Co. Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 11.16% ₩35.05 Billion
≈ $23.75 Million
₩314.06 Billion
≈ $212.83 Million
-3.77pp
2023-12-31 14.93% ₩42.69 Billion
≈ $28.93 Million
₩285.90 Billion
≈ $193.75 Million
+13.77pp
2022-12-31 1.16% ₩2.64 Billion
≈ $1.79 Million
₩227.38 Billion
≈ $154.09 Million
-15.05pp
2021-12-31 16.21% ₩32.85 Billion
≈ $22.26 Million
₩202.70 Billion
≈ $137.37 Million
-0.47pp
2020-12-31 16.68% ₩26.40 Billion
≈ $17.89 Million
₩158.31 Billion
≈ $107.29 Million
+7.04pp
2019-12-31 9.64% ₩14.20 Billion
≈ $9.62 Million
₩147.29 Billion
≈ $99.82 Million
-12.96pp
2018-12-31 22.60% ₩27.57 Billion
≈ $18.69 Million
₩122.01 Billion
≈ $82.68 Million
+15.07pp
2017-12-31 7.53% ₩7.98 Billion
≈ $5.41 Million
₩106.06 Billion
≈ $71.87 Million
-2.99pp
2016-12-31 10.52% ₩6.27 Billion
≈ $4.25 Million
₩59.67 Billion
≈ $40.44 Million
+6.68pp
2015-12-31 3.83% ₩616.99 Million
≈ $418.12K
₩16.10 Billion
≈ $10.91 Million
-16.76pp
2014-12-31 20.59% ₩16.90 Billion
≈ $11.45 Million
₩82.08 Billion
≈ $55.62 Million
+3.10pp
2013-12-31 17.49% ₩16.89 Billion
≈ $11.44 Million
₩96.56 Billion
≈ $65.44 Million
+5.28pp
2012-12-31 12.21% ₩15.90 Billion
≈ $10.77 Million
₩130.20 Billion
≈ $88.24 Million
-11.71pp
2011-12-31 23.92% ₩30.15 Billion
≈ $20.43 Million
₩126.03 Billion
≈ $85.41 Million
+1.75pp
2009-12-31 22.17% ₩31.70 Billion
≈ $21.48 Million
₩143.00 Billion
≈ $96.91 Million
-25.34pp
2008-12-31 47.51% ₩85.27 Billion
≈ $57.78 Million
₩179.47 Billion
≈ $121.63 Million
-2.02pp
2007-12-31 49.53% ₩77.56 Billion
≈ $52.56 Million
₩156.60 Billion
≈ $106.13 Million
+24.85pp
2006-12-31 24.67% ₩33.75 Billion
≈ $22.87 Million
₩136.78 Billion
≈ $92.69 Million
--
pp = percentage points

About Synergy Innovation Co. Ltd

KQ:048870 Korea Biotechnology
Market Cap
$107.71 Million
₩158.94 Billion KRW
Market Cap Rank
#18998 Global
#908 in Korea
Share Price
₩1804.00
Change (1 day)
-2.70%
52-Week Range
₩1682.00 - ₩3065.00
All Time High
₩19100.00
About

Synergy Innovation Co., Ltd. engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea. It produces and sells various culture media for hospitals, pharmaceuticals, and food/cosmetics; manufactures synergy innovation " universal transport solutions (SI-UTS); and invests and develops in various fields comprising mic… Read more